載入...

Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds

Introduction. Given its efficacy and safety, NexoBrid™ (NXB) has become part of our therapeutic options in burns treatment with satisfactory results. However, no cost analysis comparing NXB to the standard of care (SOC) has been carried out as of today. Aim. To assess the cost of treatment with NXB...

全面介紹

Na minha lista:
書目詳細資料
發表在:Biomed Res Int
Main Authors: Giudice, Giuseppe, Filoni, Angela, Maggio, Giulio, Bonamonte, Domenico, Vestita, Michelangelo
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5331316/
https://ncbi.nlm.nih.gov/pubmed/28293640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9567498
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!